{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Visit mskcc.org
Client logo
  • Sign In
  • Live Courses
  • Online Courses
  • Travel & Accommodations
  • About
  • Contact Us
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Select Login Provider

Click a button below to login.




Enter your email and password to login:








Forgot Your Password? | Don't have an account?
Go back to providers list button Go Back to Provider Selection

Forgot Your Password?






Go back to login button Go Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Need an Account?

Enter Your Information. *All fields are required.








Please enter your degree:

*Profession can be updated in the “My Profile” area

*Additional credit eligibilities can be updated in the “My Profile” area

Empty Box that can be used later for a new control but makes the formatting work now instead of a bunch of random CSS



Go Back to Login button Go Back to Login
Close Search
Site Search: Enter your search terms in the field below to view results.
Close Specialties

State of the Art Ovarian Cancer Conference 2016

State of the Art Ovarian Cancer Conference 2016 Banner

  • Overview
  • Register
  • Faculty
  • Schedule
  • Brochure
Add to Calendar State of the Art Ovarian Cancer Conference 2016 10/6/2016 7:30:00 AM 10/6/2016 5:30:00 PM America/New_York Zuckerman Research Center 417 E 68th St false MM/DD/YYYY


Date & Location
Thursday, October 6, 2016, 7:30 AM - 5:30 PM, Zuckerman Research Center 417 E 68th St, New York, NY

Specialties
General and Family Practice, Internal Medicine , Medical Oncology, Nurse Practitioner, Nursing, Obstetrics and Gynecology, Physician Assistant, Research Fellow

Overview

Advances in women’s health research provide important opportunities to enhance the screening and prevention of ovarian cancer. New modalities in the treatment of the disease provide the ability to individualize therapy, accomplish best clinical outcomes, and optimize the patient experience.

The target audience includes all clinicians, scientists and advocates interested in women’s health, and in optimizing the prevention, screening and treatment for ovarian cancer.  Clinicians including OB/GYNs, surgical/medical/gynecologic oncologists, primary care physicians, physician assistants, nurse practitioners, nurses, fellows and residents and other healthcare professionals are welcome.

Sponsors

This activity is supported by educational grants from:

  • Medtronic
  • Myriad Genetic Laboratories
  • ThermaSolutions, Inc

Objectives
  1. Discuss new genetic panel testing and its implication, results of recent ovarian cancer screening trial, and strategies for ovarian cancer risk-reduction.
  2. Present new algorithms for imaging and surgical case selection.
  3. Evaluate emerging opportunities in clinical trial options, individualized treatment, and enhanced patient experience.

Registration

Registration Fees
MDs, PhDs and DOs $350
MSK Alliance* and MSK Alumni $250
Residents, Fellows, RNs and Other Healthcare Providers $150
Industry Members* $800

*Industry Members: Registration is for educational purposes only. Marketing, sales, and promotion of products and services are prohibited at CME activities.
*MSK Alliance Members: If you are a MSK Alliance member, please email us at cme@mskcc.org with your affiliation for discount information.

Special CME Discount 

If you register for this course, you will also receive a discounted rate for our Intraoperative Imaging Technologies for Cancer Detection and Treatment course.  A promo code will emailed to you after registering

Advocacy Groups

If you are interested in attending this course in a group of 4 with opportunity to provide participants information regarding your organization during the course, please contact cme@mskcc.org or call 646-227-2025 for more information.

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course (cme@mskcc.org).Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.

Accommodations

For information on hotels in the area of MSK with discounted rates, please visit: www.mskcc.org/accommodations.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This form has expired.

Course Directors

Ginger J. Gardner, MD, FACOG
Kara Long Roche, MD, MSc, FACOG

Faculty

Nadeem Abu-Rustum, MD, FACOG, FACS
Chief Attending
MSK
New York, NY
Carol Aghajanian, MD
Chief Attending
MSK
New York, NY
Rick Boulay, MD
Chief, Division of Gynecologic Oncology
Lehigh Valley Health Network
Allentown, PA
Jeff Boyd, PhD
Director
Miami Cancer Institute – Baptist Health South Florida
Coral Gables, FL
Carol Brown, MD
Attending
MSK
New York, NY
Karen Cadoo, MD
Assistant Attending L1
MSK
New York, NY
Dennis S. Chi, MD
Attending
MSK
New York, NY
Jonathan A Cosin, MD
Chief, Gynecologic Oncology, The Hospital of Central Connecticut
Hartford Health Care Cancer Institute
New Britain, CT
Ginger J Gardner, MD
Associate Attending
MSK
New York, NY
Rachel Grisham, MD
Assistant Attending
MSK
New York, NY
Martee Hensley, MD
Attending
MSK
New York, NY
David Hyman, MD
Chief, Asst Attend
MSK
Elizabeth Jewell, MD
Associate Attending
MSK
New York, NY
Jason Konner, MD
Chief, Assoc Attend
MSK
Morganville, NJ
Mario Leitao, MD, FACOG
Attending
MSK
New York, NY
Kara Long Roche, MD, MSc
Assistant Attending
MSK
New York, NY
Roisin O'Cearbhaill, MD
Assistant Attending
MSK
New York, NY
Mark Robson, MD
Chief Attending
MSK
New York, NY
Paul Sabbatini, MD
Deputy Physician-in-Chief
MSK
NEw York, NY
Yukio Sonoda, MD
Attending
MSK
New York, NY
Robert Soslow, MD
Attending
MSK
New York, NY
William Tew, MD
Associate Attending
MSK
New York, NY
Dmitriy Zamarin, MD PhD
Assistant Attending L1
MSK
New York, NY
Oliver Zivanovic, MD, PhD
Assistant Attending
MSK
New York, NY

Thursday, October 6, 2016

October 6, 2016

REGISTRATION & BREAKFAST
7:30AM - 8:00AM
ZRC Lobby
Disclosures
7:55AM - 8:00AM
Welcoming Remarks
8:00AM - 8:15AM
Nadeem Abu-Rustum, MD, FACOG, FACS
Dennis S. Chi, MD
ZRC Auditorium
Alliance Participation and Expansion
8:15AM - 8:30AM
ZRC Auditorium
Identification and Evaluation of the High Risk Patient: What should be included in Routine Women’s Health Care?
8:30AM - 8:50AM
Kara Long Roche, MD, MSc
ZRC Auditorium
Updates from UKTOCS Screening Trial
8:50AM - 9:10AM
Jeff Boyd, PhD
ZRC Auditorium
Panel Testing: the Evolving Landscape of Genetic Tests and Implications
9:10AM - 9:40AM
Mark Robson, MD
ZRC Auditorium
What is the Role of the Fallopian Tube in Ovarian Cancer Development?
9:40AM - 10:00AM
Robert Soslow, MD
ZRC Auditorium
Debate: Risk-Reducing Surgical Options PRO: BSO is “the Way to Go”
10:00AM - 10:15AM
Mario Leitao, MD, FACOG
ZRC Auditorium
Debate: Risk-Reducing Surgical Options CON: Salpingectomy is the New Standard
10:00AM - 10:15AM
Kara Long Roche, MD, MSc
ZRC Auditorium
Discussion
10:15AM - 10:30AM
BREAK
10:30AM - 10:45AM
ZRC Lobby
MSKCC Resectability Algorithm for Primary Debulking Surgery
10:45AM - 11:00AM
Oliver Zivanovic, MD, PhD
ZRC Auditorium
Surgical Progress for Newly Diagnosed Ovarian Cancer and Outcomes
11:00AM - 11:30AM
Dennis S. Chi, MD
ZRC Auditorium
Precision Imaging: CT Scan and Protocol Enhancement
11:30AM - 11:50AM
ZRC Auditorium
Discussion
11:50AM - 12:00PM
LUNCH
12:00PM - 1:00PM
ZRC Lobby
New Treatment Options: Dose Dense vs Intraperitoneal Treatment
1:00PM - 1:30PM
Roisin O'Cearbhaill, MD
ZRC Auditorium
Targeted Therapy for Ovarian Cancer: Flying with Biologics
1:30PM - 2:00PM
Jason Konner, MD
ZRC Auditorium
The New Horizon in Immunotherapy
2:00PM - 2:20PM
Dmitriy Zamarin, MD PhD
ZRC Auditorium
Discussion
2:20PM - 2:30PM
BREAK
2:30PM - 2:45PM
ZRC Lobby
Surgery for Recurrent Disease: Optimizing Case Selection and Outcomes
2:45PM - 3:00PM
Ginger J Gardner, MD
ZRC Auditorium
HIPEC Chemo Wash – Current Data and Prospective Trial Design
3:00PM - 3:15PM
Oliver Zivanovic, MD, PhD
ZRC Auditorium
Pathway to an Enhanced Recovery
3:15PM - 3:30PM
Yukio Sonoda, MD
ZRC Auditorium
Optimal Chemotherapy for Recurrent Disease
3:30PM - 3:45PM
Paul Sabbatini, MD
ZRC Auditorium
BREAK
3:45PM - 4:00PM
ZRC Lobby
Debate: Clinical Trial Options New “Basket Trials” and Targeted Treatments are Ideal
4:00PM - 4:30PM
David Hyman, MD
ZRC Auditorium
Debate: Clinical Trial Options Traditional Clinical Trials have Strongest Rationale
4:00PM - 4:30PM
Carol Aghajanian, MD
ZRC Auditorium
Factoring in Age: Chemotherapy and Surgery
4:30PM - 4:45PM
William Tew, MD
ZRC Auditorium
Opportunities in Exercise Oncology
4:45PM - 5:00PM
Karen Cadoo, MD
ZRC Auditorium
Patient Reported Outcomes
5:00PM - 5:15PM
Elizabeth Jewell, MD
ZRC Auditorium
Closing Remarks
5:15PM - 5:30PM
Ginger J Gardner, MD
ZRC Auditorium
COCKTAIL RECEPTION
5:30PM - 6:30PM

Live courses | Contact us | Faculty Forms |Disclosure Form | Sign In

Subscribe to MSK CME announcements >

Legal Disclaimer | Privacy Policy | Public Notices

© 2018 Memorial Sloan Kettering Cancer Center